FDA Approves Pancreatic Enzyme Products to Aid Digestion

02 Mar 2012 --- Ultresa is a delayed-release capsule used to treat children and adults with cystic fibrosis, a serious genetic disorder affecting the lungs and other organs, or other conditions who cannot digest food normally because their pancreas does not make enough pancreatic enzymes.

Mar 2 2012 --- Two new pancreatic enzyme products used to help aid food digestion, Ultresa (pancrelipase) and Viokace (pancrelipase), were approved by the U.S. Food and Drug Administration.

Ultresa is a delayed-release capsule used to treat children and adults with cystic fibrosis, a serious genetic disorder affecting the lungs and other organs, or other conditions who cannot digest food normally because their pancreas does not make enough pancreatic enzymes.

Viokace, in combination with a proton pump inhibitor, is used to treat adults who cannot digest food normally. Adults with chronic pancreatitis, a continuing, chronic inflammatory process of the pancreas, or those who have had some or all of their pancreases removed (pancreatectomy) may not digest food normally because they lack needed enzymes or because their enzymes are not released into the bowel (intestine). Viokace’s safety and efficacy in children has not been established.

“The approvals of Ultresa and Viokace, along with the other approved pancreatic enzyme products, allow health care providers to prescribe the product that is most appropriate for the estimated 200,000 patients in the United States who have pancreatic insufficiency,” said Julie Beitz, M.D., director of the Office of Drug Evaluation III in FDA’s Center for Drug Evaluation and Research.

Ultresa and Viokace are the fourth and fifth pancreatic enzyme products approved by FDA. Other FDA-approved pancreatic enzyme products include Creon (2009), Zenpep (2009) and Pancreaze (2010). Approved pancreatic enzyme products meet FDA standards for safety, efficacy and product quality.

Unapproved pancreatic enzyme products had been available for many years. FDA established a date of April 28, 2010 for the makers of pancreatic enzyme products to stop manufacturing and distributing unapproved products.

Ultresa and Viokace are marketed by Bridgewater, N.J.-based Aptalis Pharma U.S. Inc.
 

Related Articles

Health & Nutrition News

Benexia Oil is First Chia Oil Authorized on the European Market As Novel Food

28 Nov 2014 --- After introducing in Europe the Chia Seed (Salvia hispanica L.) for its exceptional nutritional value, BENEXIA brings for the first time to the European market its Chia Oil, a very promising new product for the food and nutraceutical industry. BENEXIA products are produced by Functional Product Trading S.A. in Chile and exclusively distributed in Europe and Asia by Ingredia Nutritional.

Food Ingredients News

Arla Foods Ingredients Predicts Healthy Snacking Revolution

28 Nov 2014 --- Snacks that are healthy, tasty and easy to consume are set to shape the future of how people eat and drink, according to Arla Foods Ingredients.

Health & Nutrition News

Study: Appropriate Reference Amounts Important For Effective Nutrition Labeling

27 Nov 2014 --- A recent study by Professor Monique Raats of the University of Surrey’s Food, Consumer Behaviour and Health Research Centre, in conjunction with the European Food Information Council (EUFIC) in Brussels, has shown that consumers do take into account reference amounts displayed on front of pack nutrition labelling when making their judgements of healthfulness, thus highlighting their importance for the effective presentation of nutrition information.

Health & Nutrition News

Volac: Cradle-to-Grave Benefits Set To Drive Protein Beyond a Trend in 2015

27 Nov 2014 --- Infant and sports nutrition continue as the biggest markets for protein, led mainly by whey proteins, targeting a fairly young group of consumers. But a range of new protein sources is now reaching wider into adult mainstream and, according to Volac, protein is here to stay.

More Articles
URL : http://www.nutritioninsight.com:80/news/FDA-Approves-Pancreatic-Enzyme-Products-to-Aid-Digestion.html